SPHERA FUNDS MANAGEMENT LTD.
TEL AVIV, L3 · CIK 1496201 · 13F filing filed 2026-08-14
Exempt reporting adviser since 2021 · other (specify)
- Private funds1 (1 hedge) · $849.7m gross assets
- Websitespherafund.com
- Form ADV · 2026-03-17SEC adviser record
- Legal entityספרה ניהול קרנות בע"מ (IL)
- Kindhedge funds
- Others nearbyTel Aviv
As an employer
- Offices in1 country
- Private fundshedge 1
$698.8m
reported value
+20.2% vs Q1 2026
97positions
36.5%in top 10
22 new
33 added
28 reduced
17 sold out
vs Q1 2026
Options: 6 call positions ($41.3m notional), 2 put positions ($26.4m notional) – listed below, not included above.
This report includes the holdings of 2 other managers that share the investment decisions:
- Sphera Global Healthcare GP Ltd. – reports through this filing
- Sphera Global Healthcare Management LP – reports through this filing
Shares in two reports are counted once in each security's totals.
Holdings, Q2 2026
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | $50.8m7.27% | Added +363.1k |
| MINERALYS THERAPEUTICS INC MLYS | $39.7m5.68% | Added +130.0k |
| TOWER SEMICONDUCTOR LTD TSEM | $28.2m4.04% | Reduced -37.5k |
| SYNDAX PHARMACEUTICALS INC SNDX | $22.2m3.17% | Added +290.0k |
| BIOGEN INC BIIB | $20.9m2.99% | Added +4.1k |
| ULTRAGENYX PHARMACEUTICAL IN RARE | $19.6m2.81% | Reduced -220.8k |
| BIOMARIN PHARMACEUTICAL INC BMRN | $18.8m2.69% | Added +188.7k |
| CYTOKINETICS INC CYTK | $18.7m2.68% | Added +180.2k |
| BRIDGEBIO PHARMA INC BBIO | $18.3m2.61% | Added +100 |
| COGENT BIOSCIENCES INC COGT | $17.8m2.54% | Added +43.0k |
| NOVA LTD NVMI | $13.7m1.96% | Reduced -28.2k |
| INSMED INC INSM | $12.7m1.81% | New |
| MAZE THERAPEUTICS INC MAZE | $12.5m1.78% | Added +190.2k |
| ASTRAZENECA PLC AZN | $11.9m1.70% | Unchanged |
| SANOFI SNY | $11.5m1.65% | Unchanged |
| CYBIN INC COM NEW | $10.7m1.53% | Added +633.7k |
| ELI LILLY & CO LLY | $9.6m1.38% | Reduced -1.0k |
| MADRIGAL PHARMACEUTICALS INC MDGL | $9.4m1.34% | Added +8.4k |
| TREVI THERAPEUTICS INC TRVI | $9.3m1.33% | Reduced -75.0k |
| ACADIA PHARMACEUTICALS INC ACAD | $9.0m1.29% | Added +100.3k |
| CELLDEX THERAPEUTICS INC NEW CLDX | $9.0m1.28% | Reduced -2.7k |
| RHYTHM PHARMACEUTICALS INC RYTM | $8.9m1.28% | New |
| ORIC PHARMACEUTICALS INC ORIC | $8.2m1.17% | Added +215.4k |
| LAM RESEARCH CORP LRCX | $8.0m1.15% | New |
| APPLIED MATLS INC AMAT | $8.0m1.14% | New |
| TANGO THERAPEUTICS INC TNGX | $7.9m1.14% | Reduced -89.3k |
| NOVARTIS AG NVS | $7.8m1.12% | Added +13.0k |
| SOLAREDGE TECHNOLOGIES INC SEDG 2.25 07.01.29 | $7.7m1.11% | Unchanged |
| VOR BIOPHARMA INC VOR | $7.7m1.10% | Added +94.5k |
| ABBVIE INC ABBV | $7.6m1.09% | Unchanged |
| MERCK & CO INC MRK | $7.5m1.08% | Added +10.0k |
| JOHNSON & JOHNSON JNJ | $7.3m1.05% | Unchanged |
| IDEAYA BIOSCIENCES INC IDYA | $7.3m1.05% | New |
| IMMATICS N.V IMTX | $7.3m1.04% | Added +24.0k |
| NUVECTIS PHARMA INC NVCT | $7.0m1.01% | New |
| PFIZER INC PFE | $6.9m0.99% | Added +100.0k |
| HARMONY BIOSCIENCES HLDGS IN HRMY | $6.4m0.92% | New |
| XENON PHARMACEUTICALS INC XENE | $6.3m0.91% | Reduced -22.0k |
| CLIMB BIO INC CLYM | $6.3m0.90% | Added +64.5k |
| ZENAS BIOPHARMA INC ZBIO | $5.9m0.84% | Added +16.5k |
| NOVO-NORDISK A S NVO | $5.8m0.83% | Unchanged |
| ENLIVEN THERAPEUTICS INC ELVN | $5.7m0.82% | Reduced -40.5k |
| PRELUDE THERAPEUTICS INC PRLD | $5.4m0.78% | Added +461.5k |
| GSK PLC GSK | $5.3m0.77% | Reduced -20.0k |
| FORTE BIOSCIENCES INC FBRX | $5.3m0.76% | Added +64.7k |
| BIOAGE LABS INC BIOA | $5.2m0.75% | Added +127.2k |
| SCHOLAR ROCK HLDG CORP SRRK | $5.2m0.74% | Unchanged |
| SATELLOS BIOSCIENCE INC MSLE | $5.1m0.73% | Added +163.4k |
| PALISADE BIO INC PALI | $4.7m0.68% | Added +523.6k |
| ELEDON PHARMACEUTICALS INC ELDN | $4.7m0.67% | Reduced -580.9k |
| VISTRA CORP VST | $4.7m0.67% | New |
| TALEN ENERGY CORP TLN | $4.7m0.67% | New |
| SAVARA INC SVRA | $4.7m0.67% | Added +17.0k |
| DISC MEDICINE INC IRON | $4.6m0.66% | Added +10.0k |
| GLOBAL X FDS CLOU | $4.5m0.64% | New |
| DYNE THERAPEUTICS INC DYN | $4.4m0.63% | Added +39.0k |
| RELAY THERAPEUTICS INC RLAY | $4.4m0.63% | Reduced -174.6k |
| AVALO THERAPEUTICS INC AVTX | $4.3m0.61% | New |
| PROMIS NEUROSCIENCES INC PMN | $4.3m0.61% | Unchanged |
| BIOCRYST PHARMACEUTICALS INC BCRX | $4.2m0.60% | Reduced -444.4k |
| REVOLUTION MEDICINES INC RVMD | $4.2m0.60% | Reduced -32.7k |
| CABALETTA BIO INC CABA | $4.1m0.59% | New |
| GENERATE BIOMEDICINES INC GENB | $4.1m0.59% | Added +60.0k |
| MEDIWOUND LTD MDWD | $4.0m0.57% | Unchanged |
| ALPHA COGNITION INC ACOG | $3.9m0.56% | Reduced -21.8k |
| WAVE LIFE SCIENCES LTD 96663EUR | $3.7m0.53% | Added +90.0k |
| CORVUS PHARMACEUTICALS INC CRVS | $3.7m0.52% | Reduced -3.0k |
| OVID THERAPEUTICS INC OVID | $3.6m0.52% | Reduced -269.8k |
| BRIDGEBIO ONCOLOGY THERAPEUT BBOT | $3.5m0.50% | New |
| CYTOMX THERAPEUTICS INC CTMX | $3.3m0.47% | Added +659.0k |
| PROQR THRAPEUTICS N V PRQR | $3.3m0.47% | New |
| ALNYLAM PHARMACEUTICALS INC ALNY | $3.3m0.47% | New |
| KURA ONCOLOGY INC KURA | $3.2m0.46% | Reduced -483 |
| KODIAK SCIENCES INC KOD | $3.2m0.46% | Reduced -33.0k |
| ORMAT TECHNOLOGIES INC ORA | $3.1m0.44% | Reduced -40.2k |
| CONTINEUM THERAPEUTICS INC CTNM | $3.0m0.43% | Added +10.0k |
| LARIMAR THERAPEUTICS INC LRMR | $2.8m0.40% | New |
| IMMIX BIOPHARMA INC IMMX | $2.8m0.40% | New |
| AMGEN INC AMGN | $2.7m0.39% | Unchanged |
| BIOHAVEN LTD BHVN | $2.4m0.35% | Reduced -429.6k |
| CONSTELLATION ENERGY CORP CEG | $2.4m0.35% | New |
| VERASTEM INC VSTM | $2.4m0.35% | Added +289.0k |
| TENAX THERAPEUTICS INC TENX | $1.7m0.25% | Reduced -15.8k |
| TAYSHA GENE THERAPIES INC TSHA | $1.7m0.24% | New |
| STRUCTURE THERAPEUTICS INC GPCR | $1.5m0.22% | Reduced -22.2k |
| UPSTREAM BIO INC UPB | $1.5m0.22% | Reduced -138.3k |
| VOYAGER THERAPEUTICS INC VYGR | $1.5m0.21% | Reduced -42.2k |
| ORGANOGENESIS HLDGS INC ORGO | $1.3m0.19% | Unchanged |
| INHIBIKASE THERAPEUTICS INC IKT | $1.3m0.19% | New |
| CURIS INC COM | $1.0m0.15% | Reduced -1.9m |
| SHATTUCK LABS INC STTK | $600.0k0.09% | Reduced -194.3k |
| FIRST TRACKS BIOTHERAPEUTICS TRAX | $560.9k0.08% | New |
| SKYE BIOSCIENCE INC COM NEW | $470.7k0.07% | Unchanged |
| TRAWS PHARMA INC TRAW | $336.0k0.05% | New |
| EVOMMUNE INC EVMN | $300.8k0.04% | Reduced -55.6k |
| WEREWOLF THERAPEUTICS INC HOWL | $225.6k0.03% | Unchanged |
| APREA THERAPEUTICS INC APRE | $216.6k0.03% | Unchanged |
Sold out since Q1 2026
| Security | Value then |
|---|---|
| AMICUS THERAPEUTICS INC FOLD | $8.7m603.4k shares |
| CELLEBRITE DI LTD CLBT | $8.7m631.5k shares |
| APELLIS PHARMACEUTICALS INC APLS | $8.6m214.9k shares |
| PALO ALTO NETWORKS INC PANW | $8.5m52.8k shares |
| CAMTEK LTD CAMT | $8.0m53.0k shares |
| SOLENO THERAPEUTICS INC SLNO | $7.2m216.3k shares |
| AMAZON COM INC AMZN | $6.7m31.9k shares |
| APPLIED OPTOELECTRONICS INC AAOI | $6.2m73.4k shares |
| ENPHASE ENERGY INC ENPH | $5.4m142.4k shares |
| ZIM INTEGRATED SHIPPING SERV ZIM | $2.8m106.0k shares |
| SOLAREDGE TECHNOLOGIES INC SEDG | $2.7m52.8k shares |
| ISHARES BITCOIN TRUST ETF IBIT | $2.3m59.5k shares |
| ASCENDIS PHARMA A/S | $1.8m8.0k shares |
| BRISTOL-MYERS SQUIBB CO BMY | $1.1m17.5k shares |
| NICE LTD NICE | $618.7k5.6k shares |
| PRECISION BIOSCIENCES INC DTIL | $220.0k40.0k shares |
| FOGHORN THERAPEUTICS INC FHTX | $58.4k12.2k shares |
Options (notional value)
| Underlying | Notional | Change |
|---|---|---|
| SPDR SER TR XBI · Put | $23.7m150.0k shares | Reduced |
| BIOGEN INC BIIB · Call | $21.6m100.0k shares | New |
| CYTOKINETICS INC CYTK · Call | $8.5m100.0k shares | Reduced |
| PRAXIS PRECISION MEDICINES I PRAX · Call | $4.2m12.5k shares | New |
| ISHARES TR TLT · Call | $4.1m47.0k shares | Unchanged |
| ABIVAX SA ABVX · Put | $2.7m20.0k shares | New |
| TENAX THERAPEUTICS INC TENX · Call | $1.9m127.6k shares | New |
| ORIC PHARMACEUTICALS INC ORIC · Call | $1.1m100.0k shares | New |
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.
| Company | Stake |
|---|---|
| PROMIS NEUROSCIENCES INC PMN · 13G · filed 2026-02-05 | 7.8% |
| TENAX THERAPEUTICS INC TENX · 13G · filed 2026-10-13 | 7.1%≈ $38.8m |